March 24, 2020 / 12:33 PM / 7 days ago

BRIEF-Bridgebio Pharma Experiencing Delays In Or Temporary Suspension Of Enrollment Of Patients In Subsidiaries' Ongoing Clinical Trials

March 24 (Reuters) - BridgeBio Pharma Inc:

* BRIDGEBIO PHARMA INC - EXPERIENCING DELAYS IN OR TEMPORARY SUSPENSION OF ENROLLMENT OF PATIENTS IN SUBSIDIARIES’ ONGOING CLINICAL TRIALS

* BRIDGEBIO PHARMA INC - EXPECT TO EXPERIENCE DELAYS IN CERTAIN ONGOING KEY PROGRAM ACTIVITIES, INCLUDING COMMENCEMENT OF PLANNED CLINICAL TRIALS Source text: (bit.ly/39hpDns) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below